Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy

Diabetologia

Volumn 43, Issue 1, 2000, Pages 91-100

  Sanai, T ^a   Sobka, T ^a   Johnson, T ^a   El Essawy, M ^a   Muchaneta Kubara, E C ^a   Ben Gharbia, O ^a   Oldroyd, S ^a   El Nahas, A M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cytoskeletal proteins; Diabetic nephropathy; Vimentin; smooth muscle actin

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CYTOSKELETON PROTEIN; INSULIN; MESSENGER RNA; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034014246     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050012     Document Type: Article

References (26)

1. 1. Breyer JA (1992) Diabetic nephropathy in insulin-dependent patients. Am J Kidney Dis 20: 533-547
2. 2. Hostetter TH, Rennke HG, Brenner BM (1988) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 318: 140-145
3. 3. Rasch R (1988) Non-glomerular lesions in the diabetic kidney. Nephrology (Proceedings of the Xth International Congress of Nephrology) I: 744-760 p
4. 4. Ziyadeh FN, Goldfarb S (1991) The renal tubulointerstitium in diabetes mellitus. Kidney Int 39: 464-475
5. 5. El Nahas AM, Muchaneta-Kubara EC, Zhang G, Adam A, Goumenos D (1996) Phenotypic changes in the pathogenesis of renal scarring. Kidney Int 49 [Suppl 54]:S23-S27
6. 6. Johnson RJ, Ida H, Alpers C et al. (1991) Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: α-smooth muscle actin as a marker of mesangial cell proliferation. J Clin Invest 87: 847-858
7. 7. El Nahas AM, Muchaneta-Kubara EC, Tamimi N, Goumenos D (1999) Glomerulosclerosis: The role of interstitial myofibroblasts in its pathogenesis. Curr Top in Pathol 93: 167-172
8. 8. Muchaneta-Kubara EC, El Nahas AM (1997) Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 12: 904-915
9. 9. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, El Nahas AM (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12: 43-50
10. 10. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillensen D, Gabbiani G (1986) A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle cell differentiation. J Cell Biol 103: 2787-2796
11. 11. Nouwen EJ, Verstepen WA, Buyssens N, Zhu M-Q, De Broe M (1994) Hyperplasia, hypertrophy and phenotypic alterations in the distal nephron after proximal tubular injury in the rat. Lab Invest 70: 479-493
12. 12. Raij L, Azar S, Keane W (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143
13. 13. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M (1994) TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45: 525-536
14. 14. Williams MA, Lowrie JI (1987) In: Bach FH, Lock EA (eds) Fixation of tissue for morphometric study. Nephrotoxicity in Experimental Clinical Situations. Part 1. Dordrecht, Nijhoff, pp 141-166
15. 15. McHugh KM, Lessard JL (1988) The nucleotide sequence of a rat vascular smooth muscle alpha-actin cDNA. Nucleic Acids Res 16: 4167
16. 16. Herrmann H, Fouquet B, Franke WW (1989) Expression of intermediate filament proteins during development of Xenopus laevis I. cDNA clones encoding different forms of vimentin. Development 105: 279-298
17. 17. Steffes MW, Osterby R, Chavers B, Mauer M (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081
18. 18. Desmouliere A, Gabbiani G (1994) Modulation of fibroblastic cytoskeletal features during pathological situations: The role of extracellulare matrix and cytokines. Cell Motil Cytoskeleton 29: 195-203
19. 19. Kempe HP, Engelman K, Gretz N, Hasslacher C (1993) Models of diabetes for studying diabetic nephropathy. In: Gretz N, Strauch M (eds) Experimental and Genetic rat Models of Chronic Renal Failure. Basel, Karger, pp 148-155
20. 20. Goumenos D, Brown CB, Shortland J, El Nahas AM (1994) Myofibroblasts and the progression of IgA nephropathy. Nephrol Dial Transplant 9: 1418-1425
21. 21. Young BA, Johnson RJ, Alpers CE et al. (1995) Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944
22. 22. Terzi F, Henrion E, Colucci-Guyon E et al. (1996) Subtotal nephrectomy (Nx) is lethal in vimentin-null mice: Role of endothelin. J Am Soc Nephrol 7: 1574
23. 23. Mandal AK, Lemley-Gillepsie S, Nafz MA, Khamis HJ (1996) Glucose modulates vimentin assembly associated with endothelin production in cultured human endothelial cells. J Am Soc Nephrol 7: 1568
24. 24. Terzi F, Maunoury R, Colucci-Guyon E et al. (1997) Normal tubular regeneration and differentiation of the post-ischemic kidney in mice lacking vimentin. Am J Pathol 150: 1361-1371
25. 25. Strutz F, Caron P, Tomaszewski I, Fumo P, Ziyadeh F, Neilson EG (1994) Transdifferentiation; a new concept in renal fibrogenesis. J Am Soc Nephrol 5: 819
26. 26. Thomas S, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ (1998) Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9: 231-242